期刊
CURRENT OPINION IN MICROBIOLOGY
卷 52, 期 -, 页码 84-89出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2019.05.008
关键词
-
类别
资金
- UK NERC [NE/P001165/1]
- UK MRC [MR/R015600/1]
- MRC [MR/R015600/1] Funding Source: UKRI
- NERC [NE/P001165/1] Funding Source: UKRI
The discovery in 2009 of a new species of yeast, Candida auris, heralded the arrival of a novel emerging human infectious disease. This review highlights the unique characteristics of C. auris that have lied to it being of public health concern worldwide, namely public health concern, namely its global emergence, its ability to cause nosocomial outbreaks in healthcare settings, its innate and emerging resistance to multiple antifungal drugs and its resilience in the face of hygiene and infection control measures. Genomic epidemiology has identified four emergences of C. auris marked by four clades of the pathogen. These clades of C. auris are genetically dissimilar and are associated with differential resistance to antifungal drugs, suggesting that they will continue to phenotypically diverge into the future. The global emergence of C. auris testifies to the unmapped nature of Kingdom Fungi, and represents a new nosocomial threat that will require enhanced infection control across diverse healthcare and community settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据